StonvexLoading…
StonvexStonvexStonvexCore line items from NIQ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $4.20B | $3.97B | $3.34B |
Operating Income | $85.40M | $-99.80M | $-108.70M |
Net Income | $-353.30M | $-798.00M | $-577.40M |
EPS (Diluted) | $-1.32 | $-3.26 | $-2.35 |
Total Assets | $6.80B | $6.37B | Not available |
Total Liabilities | $5.58B | $6.07B | Not available |
Cash & Equivalents | $518.80M | $266.20M | $283.00M |
Free Cash Flow OCF − CapEx | $264.00M | $38.50M | $-36.00M |
Shares Outstanding | 295.00M | 245.00M | 245.00M |